News | Proton Therapy | February 10, 2020

Global Radiation Therapy Market to Reach $8.6B by 2026

Growing prevalence of cancer behind high demand for radiation therapy, but high costs to restraint market from reaching full potential

The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

February 10, 2020 — Amid technological advancement, and notable research and development activities, the global radiation therapy market is set to chart a sturdy growth curve, owing to a steady growth rate of 5.2 percent from 2018 to 2026, according to a newly released report. As per Transparency Market Research (TMR), the growth is attributable to surge in product approvals, increase in expenditure on healthcare, high incidence of cancer, and a growing preference for non-invasive treatment procedures.

TMR states that, "From bench to clinic, there is a wave of therapeutic and diagnostic technologies, paving way for higher growth in oncology. And, this will aid radiation therapy witness better times to come. Over the forecast period external beam radiation therapy will dominate the market landscape."

Key Findings of the Radiation Therapy Market Study

  • Hospitals to dominate the end-user segment over the forecast period owing to robust infrastructure with state of the art-equipment and services usually available
  • External beam radiation therapy demand to account for a huge share owing to a stream of notable approvals and significant advancement in technology
  • Emerging economies to witness increase in need for radiation therapy owing to increase in incidence of cancer and growing awareness regarding the same; India and China to dominate regional demand curve

Radiation Therapy Market: Key Driving Factors

The market report, based on extensive research by Transparency Market Research, is leading to growth in the landscape. And, a wave of innovation is keeping the statistics buoyant over the period. Some of the factors that will sustain growth over the forecast period in the global radiation therapy market include the following:

  • Every year 439.2 people out of 100,000 add to the already huge pool of cancer patients worldwide and out of these 163.5 die each year
  • In United States alone, in 2018, 609,640 will die out of 1,735,350 people diagnosed with cancer
  • Approvals for products such as MRIdian Linac system, created by ViewRay, Inc., in 2017 is aiding the market chart high growth over the forecast period
  • Owing to high contribution from the United States of America, which is a large market of radiation therapy, North American region will dominate market landscape

Key Impediments for Radiation Therapy Market Players

While the overall outlook of the global radiation therapy market is positive, TMR speaks of certain restraints that will hamper growth to some extent. According to the study, the key restraints impeding market growth include,

  • High cost of treatment – unaffordable for a large chunk of people in the developing region, particularly in countries where healthcare cover is particularly low
  • Low awareness levels – Patients sometime are not aware of cancer cells wreaking havoc in the body till too late, this leads to late diagnosis
  • Radiation takes a toll on the body and the side effects make it difficult to tolerate for some patients

Radiation Therapy Market: Region-wise Analysis

  • One of the biggest revenue generators in the global radiation therapy market is the Asia Pacific region with Japan, China, and India, leading the way, credit rising levels of disposable income, and improving healthcare infrastructure
  • In countries such as India, expenses towards healthcare are increased and an effort to provide insurance cover to more and more people is set to contribute positively to regional growth
  • Large patient pool in the region and increasing awareness related to cancer symptoms and diagnosis is also a positive factor, promising to help the region chart significant growth  

Competitive Landscape

Strategic alliances and a keen focus on technological advancement is the key to growth for players operating in the global radiation therapy market over the forecast period. One of the most notable agreement that took place in the recent past – November 2018 – is that between Chengdu Xingcheng and Mevion. The aim behind the move is to lead center for proton therapy in China's sub-provincial city – Chengdu.

Besides, players are focused on product development and launch. For instance, in the year 2018, ProBeam 360 – a system of single room proton therapy - was launched by Varian Medical Systems. In the same year Hitachi Ltd. received approval for commercialization of RGPT.

Key players include Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), and Mevion Medical Systems, Inc. (US)

By Type:

External beam Radiation Therapy

  • Conformal Radiation Therapy
  • Proton Beam Therapy
  • Image Guided Radiation Therapy
  • Stereotactic Radiation Therapy

Internal Radiation Therapy

  • Brachytherapy
  • Systemic Radiation Therapy

By End user:

  • Hospitals
  • Specialty Clinics

For more information: www.transparencymarketresearch.com

Related Content

The FLASH Effect significantly improves the therapeutic ratio for curing cancer

The FLASH Effect significantly improves the therapeutic ratio for curing cancer

News | Radiation Oncology | July 28, 2021
July 28, 2021 — IntraOp Medical Corporation announced that ...
Recommendations address when and how radiation therapy should be used and outline best practices for patient-centered care

Figure 1. The guideline also includes treatment algorithms for initial local management (Figure 1) and local management following an unplanned excision (Figure 2).

News | Radiation Therapy | July 27, 2021
July 27, 2021 — A ...
Radiation oncologists urged Congress to reverse proposed CMS cuts and create more equity in access to cancer treatments

Getty Images

News | Radiation Oncology | July 26, 2021
July 26, 2021 — A record number of radiation oncologists met with Congressional leaders and staff last week as part o
The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

The 15-ton compact accelerator is lifted into the David C. Pratt Cancer Center at Mercy St. Louis. (Photo: Business Wire)

News | Radiation Oncology | July 21, 2021
July 23, 2021 — Mevion Medical Systems announced that it has delivered the 15-ton compact accelerator to...
ASTRO just issued the following statement in response to the Radiation Oncology Model update in yesterday's HOPPS proposed rule, which compounds significant and detrimental cuts to the cancer care specialty in the proposed 2022 MPFS

Getty Images

News | Radiation Therapy | July 20, 2021
July 20, 2021 — In response to consecutive weeks of proposed...
Artificial intelligence-powered diagnostic tool spots asymptomatic prostate cancer in seconds

(L-R) Associate Professor Peter Brotchie (St Vincent's), Dr Ruwan Tennakoon (RMIT), Professor John Thangarajah (RMIT), Dr Mark Page (St Vincent's). Image courtesy of St Vincent's Hospital Melbourne

News | Prostate Cancer | July 19, 2021
July 19, 2021 — Prostate cancer is the most diagnosed
Ramon Alfredo Siochi, Ph.D. — the director of medical physics at WVU — led a task group to help ensure the accuracy of data that dictates a cancer patient's radiation therapy.

Ramon Alfredo Siochi, director of medical physics at West Virginia University. Image courtesy of WVU Photo/Aira Burkhart

News | Radiation Oncology | July 15, 2021
July 15, 2021 — Just as helicopter traffic reporters use their "bird's eye view" to route drivers around roadblocks s
NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care

NeuroLogica joins forces with Massachusetts General Hospital to pilot OmniTom Elite with Photon Counting Detector (PCD) technology at patient point-of-care. (Photo: Business Wire)

News | Computed Tomography (CT) | July 13, 2021
July 13, 2021 — NeuroLogica Corp.